Winton Group LTD Vericel Corp Transaction History

Winton Group LTD

$2.35 Billion
Q3 2025

A detailed history of Winton Group LTD transactions in Vericel Corp stock. As of the latest transaction made, Winton Group LTD holds 34,766 shares of VCEL stock, worth $1.39 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

34,766

Previous 17,036 104.07%

Holding current value

$1.39 Million

Previous $724,000 51.1%

% of portfolio

0.05%

Previous 0.04%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$29.84 - $41.74 $529,063 - $740,050	17,730 Added 104.07%	34,766 $1.09 Million
Q2 2025 Aug 14, 2025	BUY	$37.92 - $45.7 $152,248 - $183,485	4,015 Added 30.83%	17,036 $724,000
Q1 2025 May 15, 2025	SELL	$44.5 - $61.8 $103,195 - $143,314	-2,319 Reduced 15.12%	13,021 $580,000
Q4 2024 Feb 12, 2025	SELL	$40.05 - $59.11 $356,445 - $526,079	-8,900 Reduced 36.72%	15,340 $842,000
Q3 2024 Nov 12, 2024	BUY	$42.25 - $53.56 $93,668 - $118,742	2,217 Added 10.07%	24,240 $1.02 Million

Q2 2024 Aug 09, 2024	BUY	$41.71 - $52.9 $1,584 - $2,010	38 Added 0.17%	22,023 $1.01 Million
Q1 2024 May 14, 2024	BUY	$32.52 - $52.33 $277,102 - $445,903	8,521 Added 63.29%	21,985 $1.14 Million
Q4 2023 Feb 12, 2024	BUY	$30.85 - $37.09 $555 - $667	18 Added 0.13%	13,464 $479,000
Q3 2023 Nov 13, 2023	BUY	$31.69 - $39.25 $252,854 - $313,175	7,979 Added 145.95%	13,446 $450,000
Q2 2023 Aug 14, 2023	BUY	$29.0 - $38.37 $158,543 - $209,768	5,467 New	5,467 $205,000
Q4 2021 Feb 10, 2022	SELL	$35.2 - $52.6 $776,582 - $1.16 Million	-22,062 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$46.35 - $59.75 $297,103 - $382,997	-6,410 Reduced 22.51%	22,062 $1.08 Million
Q2 2021 Aug 10, 2021	SELL	$47.2 - $67.81 $422,912 - $607,577	-8,960 Reduced 23.94%	28,472 $1.5 Million
Q1 2021 Jul 21, 2021	SELL	$30.93 - $59.48 $147,783 - $284,195	-4,778 Reduced 11.32%	37,432 $2.08 Million
Q4 2020 Feb 12, 2021	SELL	$18.53 - $31.5 $1.31 Million - $2.23 Million	-70,831 Reduced 62.66%	42,210 $1.3 Million
Q3 2020 Oct 30, 2020	SELL	$14.68 - $19.12 $53,890 - $70,189	-3,671 Reduced 3.15%	113,041 $2.1 Million
Q2 2020 Aug 05, 2020	BUY	$8.5 - $15.82 $470,305 - $875,320	55,330 Added 90.14%	116,712 $1.61 Million
Q1 2020 May 11, 2020	BUY	$7.25 - $19.22 $10,179 - $26,984	1,404 Added 2.34%	61,382 $563,000
Q4 2019 Feb 13, 2020	BUY	$13.77 - $19.2 $825,897 - $1.15 Million	59,978 New	59,978 $1.04 Million
Q3 2019 Nov 08, 2019	SELL	$14.93 - $19.83 $163,140 - $216,682	-10,927 Closed	0 $0
Q2 2019 Jul 08, 2019	SELL	$15.01 - $18.89 $85,872 - $108,069	-5,721 Reduced 34.36%	10,927 $206,000
Q1 2019 May 13, 2019	BUY	$16.23 - $20.29 $270,197 - $337,787	16,648 New	16,648 $292,000

Others Institutions Holding VCEL

# of Institutions

274

Shares Held

52.6M

Call Options Held

36.6K

Put Options Held

9.1K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $1.88B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account